Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China ...Middle East

PR Newswire - News
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China
OSLO, Norway, Nov. 29, 2023 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that the National Medical Products Administration (NMPA) accepted the new drug application (NDA) for...

Hence then, the article about photocure partner asieris announces new drug application acceptance for regulatory review of hexvix in china was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News